Inflammatory Bowel Disease Genetic Consortium

Acronym: IBDGC NIDDK Contact: Robert Karp Principal Investigator(s): Not Available


The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) consists of investigators from seven sites in the U.S. and Canada, who have recruited a large sample of inflammatory bowel disease patients, their relatives, and control subjects. All of the individuals in this sample have been evaluated according to a standardized protocol for clinical traits related to IBD, and have donated blood samples as a source of DNA. The IBDGC investigators are conducting genetic association studies to identify genes influencing predisposition to IBD. Phenotype and genotype data are available in dbGAP, and DNA samples are available through the NIDDK Genetics Repository.

Click outside of the light box to close the box.